Hong Kong and Macao suspend BioNTech coronavirus vaccine rollout due to packaging defect
CNN
Authorities in Hong Kong and Macao have suspended the rollout of BioNTech's Covid-19 vaccine citing a packaging defect found in their first batch of doses.
Both governments said in statements Wednesday they had received a letter from BioNTech and its Chinese partner, Fosun Pharma, indicating an issue with the seal on individual vials in batch number 210102. According to government figures, as of Tuesday, 150,200 people in Hong Kong had received their first dose of the BioNTech vaccine, which outside of China is partnered with US pharmaceutical giant Pfizer.More Related News